Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

The smaller companies in the sector are operating on thin margins and the tariffs could add on to the pressure forcing them ...

The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more af ...

Seattle-based e-bike maker Rad Power Bikes named Kathi Lentzsch as its new CEO. Lentzsch previously ran Bartell Drugs as CEO ...

India's contract drug makers have urged the government to remove regulatory hurdles and grant faster clearance to vital raw material imports at a time when many global pharmaceutical firms are ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

In Roman’s case, the question is not just hypothetical. Thundermist lost $5 million last year in potential revenue due to drug makers’ skimping on a federal program designed to help safety-net ...

Novo Nordisk says it will cut the price of Wegovy. This comes after a similar move by Zepound-maker Eli Lilly.